Treatments of choice for bullous pemphigoid.

Bullous pemphigoid (BP) is the most frequently occurring autoimmune blistering disease in Europe and North America. Although it is primarily a disease of the elderly, children and young adults can also develop it. The aim of treatment is to suppress the clinical signs and symptoms of BP without over...

Full description

Bibliographic Details
Main Authors: Cooper, S, Wojnarowska, F
Format: Journal article
Language:English
Published: 2002
_version_ 1797091172340989952
author Cooper, S
Wojnarowska, F
author_facet Cooper, S
Wojnarowska, F
author_sort Cooper, S
collection OXFORD
description Bullous pemphigoid (BP) is the most frequently occurring autoimmune blistering disease in Europe and North America. Although it is primarily a disease of the elderly, children and young adults can also develop it. The aim of treatment is to suppress the clinical signs and symptoms of BP without over-treating the patient, because BP tends to spontaneously remit in most patients within approximately 5 years. Mild or localized disease may respond to super-potent topical corticosteroids alone or in combination with tetracyclines with or without niacinamide. More severe or generalized disease usually requires systemic treatment with prednisolone (dose range from 20-70 mg/d). Additional immunosuppressant therapy is necessary for more refractory disease.
first_indexed 2024-03-07T03:29:13Z
format Journal article
id oxford-uuid:ba1bfded-e0cc-4606-81a8-6a31b5f3d40e
institution University of Oxford
language English
last_indexed 2024-03-07T03:29:13Z
publishDate 2002
record_format dspace
spelling oxford-uuid:ba1bfded-e0cc-4606-81a8-6a31b5f3d40e2022-03-27T05:07:42ZTreatments of choice for bullous pemphigoid.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ba1bfded-e0cc-4606-81a8-6a31b5f3d40eEnglishSymplectic Elements at Oxford2002Cooper, SWojnarowska, FBullous pemphigoid (BP) is the most frequently occurring autoimmune blistering disease in Europe and North America. Although it is primarily a disease of the elderly, children and young adults can also develop it. The aim of treatment is to suppress the clinical signs and symptoms of BP without over-treating the patient, because BP tends to spontaneously remit in most patients within approximately 5 years. Mild or localized disease may respond to super-potent topical corticosteroids alone or in combination with tetracyclines with or without niacinamide. More severe or generalized disease usually requires systemic treatment with prednisolone (dose range from 20-70 mg/d). Additional immunosuppressant therapy is necessary for more refractory disease.
spellingShingle Cooper, S
Wojnarowska, F
Treatments of choice for bullous pemphigoid.
title Treatments of choice for bullous pemphigoid.
title_full Treatments of choice for bullous pemphigoid.
title_fullStr Treatments of choice for bullous pemphigoid.
title_full_unstemmed Treatments of choice for bullous pemphigoid.
title_short Treatments of choice for bullous pemphigoid.
title_sort treatments of choice for bullous pemphigoid
work_keys_str_mv AT coopers treatmentsofchoiceforbullouspemphigoid
AT wojnarowskaf treatmentsofchoiceforbullouspemphigoid